AbbVie Common Stock Shares Outstanding from 2010 to 2025

ABBV Stock  USD 210.01  0.00  0.00%   
AbbVie Common Stock Shares Outstanding yearly trend continues to be fairly stable with very little volatility. Common Stock Shares Outstanding will likely drop to about 1.8 B in 2025. Common Stock Shares Outstanding is the total number of shares of a company's common stock that are currently owned by all its shareholders. View All Fundamentals
 
Common Stock Shares Outstanding  
First Reported
2011-03-31
Previous Quarter
1.8 B
Current Value
1.8 B
Quarterly Volatility
97.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.8 B, Interest Expense of 2.9 B or Selling General Administrative of 8.3 B, as well as many indicators such as Price To Sales Ratio of 3.46, Dividend Yield of 0.0288 or PTB Ratio of 99.06. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Common Stock Shares Outstanding Growth Pattern

Below is the plot of the Common Stock Shares Outstanding of AbbVie Inc over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. AbbVie's Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
Common Stock Shares Outstanding10 Years Trend
Slightly volatile
   Common Stock Shares Outstanding   
       Timeline  

AbbVie Common Stock Shares Outstanding Regression Statistics

Arithmetic Mean1,674,555,859
Geometric Mean1,669,836,600
Coefficient Of Variation7.97
Mean Deviation100,639,307
Median1,631,000,000
Standard Deviation133,445,157
Sample Variance17807.6T
Range555M
R-Value0.67
Mean Square Error10550.3T
R-Squared0.45
Significance0
Slope18,740,450
Total Sum of Squares267114.1T

AbbVie Common Stock Shares Outstanding History

20251.8 B
2024B
20231.8 B
20221.8 B
20211.8 B
20201.7 B
20191.5 B

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Common Stock Shares Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Shares OutstandingB1.8 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.